Immunoinformatics-guided design of a universal chimeric multi-epitope subunit vaccine against Marburg virus disease and Ravn virus co-infection
Abstract
Marburg Virus Disease (MVD) is a life-threatening hemorrhagic fever, caused by two viruses-Marburg virus (MARV) and Ravn virus (RAVV)-that belong to the family Filoviridae. Due to its high mortality rate and the lack of licensed vaccines, MVD remains a major global health concern. In this study, a comprehensive immunoinformatics workflow was used to design a universal chimeric multi-epitope subunit vaccine targeting conserved antigenic regions of both viruses to reduce MVD-related mortality. Antigenicity analysis identified glycoproteins (GP) of MARV and RAVV as the most immunogenic viral proteins, and multiple sequence alignment revealed conserved regions suitable for epitope selection. Three highly conserved, antigenic, non-allergenic, and non-toxic CTL, HTL, and B-cell epitopes from each virus were incorporated into the final vaccine construct. The designed vaccine exhibited high antigenicity, non-allergenicity, solubility, and acceptable physicochemical properties. Structural modeling generated a high-quality 3D structure, and molecular docking revealed stable binding to human TLR4 with a docking score of − 229.46 kcal/mol, supported by multiple hydrogen bonds and non-bonded interactions, suggesting robust immune activation potential. Codon optimization produced a CAI value of 0.96 and 52.2% GC content, indicating efficient expression in E. coli K-12, further validated through in silico cloning. Immune simulations showed robust primary and secondary immune responses,…
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.